Cargando…
1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase
A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more p...
Autores principales: | Jian, Yanlin, Risseeuw, Martijn D. P., Froeyen, Mathy, Song, Lijun, Cappoen, Davie, Cos, Paul, Munier-Lehmann, Hélène, van Calenbergh, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920704/ https://www.ncbi.nlm.nih.gov/pubmed/31822127 http://dx.doi.org/10.1080/14756366.2019.1662790 |
Ejemplares similares
-
1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors
por: Jian, Yanlin, et al.
Publicado: (2020) -
Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
por: Guillaume, Joren, et al.
Publicado: (2017) -
N-[(Piperidin-1-yl)carbothioyl]benzamide
por: Al-abbasi, Aisha A., et al.
Publicado: (2010) -
N-(2-Furylcarbonyl)piperidine-1-carbothioamide
por: Duque, J., et al.
Publicado: (2008) -
Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
por: Torfs, Eveline, et al.
Publicado: (2019)